Patent · US Active

Adaptive medium voltage therapy for cardiac arrhythmias

US8805495B2 · kind B2 · utility

6Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 19, 2013
Grant dateAug 12, 2014
Priority date
Expiry dateJun 19, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/3993
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Aspects of the invention are directed to advanced monitoring and control of medium voltage therapy (MVT) in implantable and external devices. Apparatus and methods are disclosed that facilitate dynamic adjustment of MVT parameter values in response to new and changing circumstances such as the patient's condition before, during, and after administration of MVT. Administration of MVT is automatically and dynamically adjusted to achieve specific treatment or life-support objectives, such as prolongation of the body's ability to endure and respond to MVT, specifically addressing the type of arrhythmia or other pathologic state of the patient with targeted treatment, a tiered-intensity MVT treatment strategy, and supporting patients in non life-critical conditions where the heart may nevertheless benefit from a certain level of assistance.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.